Tissue-Agnostic Cancer Drug Development: An Emerging Paradigm Shift?
Pfizer Inc. Headquarters, New York, NY
Tuesday, October 23, 2018
- Wednesday, October 24, 2018
Add to Calendar
Eastern Standard Time
Join HBA New York for a presentation and panel discussion to learn about the current development pipeline for tissue-agnostic oncology products, and implications of this trend for stakeholders across the health ecosystem.